Logrank, play the winner, power and ethics

Area of Science:

• Biostatistics
• Clinical Trials
• Epidemiology

Background:

• Clinical trials often employ allocation strategies to assign participants to treatment groups.
• Play the winner (PTW) is a dynamic allocation method aiming to minimize patient exposure to ineffective treatments.
• The logrank test is a standard statistical method for analyzing survival data in clinical trials.

Purpose of the Study:

• To evaluate the impact of play the winner strategies on the statistical power of chronic disease mortality trials.
• To assess whether PTW strategies affect the ability to detect a true treatment effect compared to standard allocation.

Main Methods:

• The study utilized simulation techniques to model chronic disease mortality trials.
• Numerical integration was employed to analyze the performance of different allocation strategies.
• The logrank test was used as the primary statistical endpoint for power calculations.

Main Results:

• Simulation results indicate that play the winner strategies have a negligible effect on the statistical power of the logrank test.
• The observed power remained largely consistent across various simulated scenarios, irrespective of the allocation method.
• This suggests PTW does not significantly enhance or diminish the trial's ability to detect treatment effects.

Conclusions:

• Play the winner strategies do not substantially alter statistical power in typical chronic disease mortality trials analyzed with the logrank test.
• The findings challenge the rationale for using complex adaptive allocation methods like PTW when power is not a significant concern.
• This raises ethical considerations regarding the principle of equal patient allocation in clinical trial design and conduct.